环丙沙星缓释鼻窦支架对铜绿假单胞菌鼻窦炎的临床前疗效
本研究在兔鼻窦炎模型中评估环丙沙星涂层鼻窦支架(CSS)清除铜绿假单胞菌(PAO-1)感染的效果。体外实验显示CSS显著抑制PAO-1生物膜形成(p < 0.0001)。体内实验将8个支架(4个假手术对照,4个CSS)单侧置入兔上颌窦,2周后评估显示CSS组鼻内镜评分(p < 0.0001)和CT评分(p < 0.002)显著改善,组织学和扫描电镜显示黏膜及黏膜下层结构明显改善且未检测到生物膜结构。结论认为CSS在临床前模型中具有稳健的治疗效果。
要点
- CSS体外显著抑制PAO-1生物膜形成(p < 0.0001)。
- 兔鼻窦炎模型置入CSS 2周后鼻内镜评分显著改善(p < 0.0001)。
- CSS组CT评分显著改善(p < 0.002),组织学与SEM未见生物膜结构。
核心结论
- CSS在兔鼻窦炎临床前模型中通过减少铜绿假单胞菌载量和生物膜形成显示出稳健的治疗效果。
研究设计与样本
- 研究在兔上颌窦炎模型中单侧置入环丙沙星缓释鼻窦支架,共8个支架(4个假手术对照,4个CSS),感染诱导1周后置入,2周后评估。
主要发现
- 体外暴露于CSS后PAO-1生物膜形成显著减少(p < 0.0001)。
- 置入支架2周后,鼻内镜评分显著改善(p < 0.0001),CT评分显著改善(p < 0.002)。
- 组织学和SEM显示CSS组黏膜及黏膜下层结构明显改善,未检测到生物膜结构。
临床怎么用
- CSS可能作为局部抗生素递送策略用于铜绿假单胞菌鼻窦炎,但需进一步临床研究验证。
局限性
- 研究样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ciprofloxacin-coated sinus stent (CSS) has unique therapeutic potential to deliver antibiotics to the sinuses. The objective of this study is to evaluate the efficacy of the CSS stent in eliminating Pseudomonas aeruginosa infection in a rabbit model of sinusitis. METHODS: A ciprofloxacin-eluting sinus stent was created by coating ciprofloxacin/Eudragit RS100 on biodegradable poly-D/L-lactic acid (2 mg). After analyzing in-vitro inhibition of P aeruginosa (PAO-1 strain) biofilm formation, a total of 8 stents (4 shams, 4 CSSs) were placed unilaterally in rabbit maxillary sinuses via dorsal sinusotomy after inducing infection for 1 week with PAO-1. Animals were assessed 2 weeks after stent insertion with nasal endoscopy, sinus culture, computed tomography (CT) scan, histopathology, and scanning electron microscopy (SEM). RESULTS: PAO-1 biofilm formation was significantly reduced in vitro with exposure to the CSS (p < 0.0001). Insertion of the stent in PAO-1-infected rabbits for 2 weeks resulted in significant improvement in sinusitis according to endoscopy scoring (p < 0.0001) and CT scoring (p < 0.002). Histology and SEM revealed marked improvement in the structure of the mucosa and submucosa with no detection of biofilm structures in the CSS cohort. CONCLUSION: Although this study had a small sample size, we identified robust therapeutic efficacy of the CSS by reducing bacterial load and biofilm formation of P aeruginosa in a preclinical model of sinusitis after placement for 2 weeks.
引用
- Cho DY, Lim DJ, Mackey C, et al. Preclinical therapeutic efficacy of the ciprofloxacin-eluting sinus stent for Pseudomonas aeruginosa sinusitis. Int Forum Allergy Rhinol. 2018. PMID: 29334430. doi:10.1002/alr.22081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。